Navigation Links
Concerned Shareholders of Biovail Pleased with Court Order for Biovail AGM
Date:7/16/2008

TORONTO, July 16 /PRNewswire/ - Eugene Melnyk and EM Holdings B.V. (The "Concerned Shareholders") said today that they were pleased with the decision of the Ontario Superior Court of Justice released this morning. The Court denied the application brought by Biovail Corporation and its CEO, William Wells, for an order validating the election of the board of directors at the shareholder meeting convened on June 25, 2008. Further, the Court determined that the Biovail Annual General Meeting was improperly constituted and must be re-convened in order to allow for the election of directors at a meeting complying with corporate law and the company's by-laws.

"Biovail's AGM was not properly constituted and there was no quorum present, as the court recognized," stated Mr. Brydon. "Remember, a majority of shareholders did not cast their votes. This is a strong indication that shareholders are deeply frustrated with the status quo at Biovail. Today's court ruling means all shareholders will have an opportunity to further evaluate the two very different visions for the future of Biovail."

The Court ordered that the Annual General Meeting be re-convened as soon as reasonably possible, but in any event, by September 23, 2008.

Mr. Melnyk and Mr. Brydon are so confident in the strength of the plan proposed by the Concerned Shareholders that they will move it forward no matter what the outcome at Biovail's re-convened Annual General Meeting. The plan will either be implemented through Biovail, if the Concerned Shareholders' nominees are elected at the re-convened Annual General Meeting, or through a new company, Trimel Biopharma, that Eugene Melnyk and Bruce Brydon have already announced they will form if the Concerned Shareholders are unsuccessful at the re-convened Annual General Meeting. Mr. Brydon will be reaching out to Biovail shareholders during the coming weeks to further discuss this plan, the opportunity to support it and benefit from its succe
'/>"/>

SOURCE Concerned Shareholders of Biovail
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Concerned Shareholders of Biovail seek court order declaring Biovail AGM illegally convened;
2. Biovail Concerned Shareholders Welcome Glass Lewis Evaluation
3. Biovail Concerned Shareholders Want Open Debate
4. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
5. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
6. Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
7. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
8. Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value
9. Spherix Holds Annual Shareholders Meeting
10. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
11. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... November 21, 2014 Two new educational webinars ... comes next for ALS research and how the pharmaceutical industry ... the Ice Bucket Challenge: Where Does the ALS Money Go? ... 2 December 2014, Time: 1:30pm ET, Register to ... speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology at ...
(Date:11/22/2014)... MA (PRWEB) November 21, 2014 ... key investors will gather on December 3rd at ... Biotech Conferences series. GeneticRx will take place at ... Medical School and will discuss the present and ... therapy, exon skipping, and gene editing—as well as ...
(Date:11/22/2014)... 2014 RURO, Inc., a leading ... released Limfinity® version 5.1.4. , RURO’s deployment teams ... than ever in RURO’s 8 year history. Many ... enhancement. Limfinity® version 5.1.4 is the perfect example ... bug fixes! , Limfinity® 5.1.4 release highlights – ...
(Date:11/22/2014)... November 22, 2014 The “Chiral ... Preparative), by Material (Metal, Glass, Plastic), by Application ... SFC] - Forecast to 2018” analyses and studies ... in North America, Europe, Asia, and Rest of ... and 15 figures spread through 135 pages and ...
Breaking Biology Technology:DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2RURO Announces Limfinity® version 5.1.4 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... BERLIN, NIMES, France and RICHMOND, Calif., June 22 ... Cezanne, and Lumiphore Inc., a biotechnology leader in ... high-value applications, announced that they have signed an ... BRAHMS diagnostic tests. , , Under ...
... solution for managing compliance and regulated content throughout the product ... SAN DIEGO, June 22 Drug Information Association ... Inc. , the market leader in enterprise content compliance ... of its Virtx integrated software suite, an end-to-end, Web-based solution ...
... , SHANGHAI, June 22 /PRNewswire-Asia/ -- ... pharmaceutical, biotechnology, and medical device,research and development outsourcing company with ... Hsu has been appointed Senior Vice,President of WuXi AppTec U.S. ... , Prior to joining WuXi, ...
Cached Biology Technology:BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests 2BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests 3Virtify, Inc. Delivers Industry's First Enterprise Content Compliance Software Suite for Life Sciences Companies 2Virtify, Inc. Delivers Industry's First Enterprise Content Compliance Software Suite for Life Sciences Companies 3Virtify, Inc. Delivers Industry's First Enterprise Content Compliance Software Suite for Life Sciences Companies 4Virtify, Inc. Delivers Industry's First Enterprise Content Compliance Software Suite for Life Sciences Companies 5WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations 2
(Date:11/5/2014)... professor of biology in the UTSA College of ... nation selected to receive a two-year $300,00 National ... Research (EAGER). The funding supports President Obama,s BRAIN ... create new technology that will demystify complex brain ... in neuroscience are broken into the interactions of ...
(Date:11/4/2014)... PA) – Temple University School of Medicine announced ... winner, an initiative funded by the Bill & ... Professor of Obstetrics, Gynecology and Reproductive Sciences; and ... Temple University School of Medicine will pursue an ... "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment.", Grand ...
(Date:11/4/2014)... VILNIUS, Lithuania , Nov. 4, 2014 /PRNewswire/ ... identification technologies, today announced that the latest version ... place in the Ongoing MINEX evaluation ... interoperability of fingerprint algorithms using the INCITS 378 ... a mandatory requirement in public tenders in ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3Temple University School of Medicine receives Grand Challenges Explorations grant 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3
... will not become pregnant, and they cannot be helped by ... Gothenburg, Sweden, have identified a molecule called Cdk1 that has ... this could lead to an increased rate of successful IVF. ... struggle to become pregnant. In vitro fertilization (IVF) can help ...
... the University of California, Davis, have invented a superthin ... "The material itself (say, semiconductor wafers) would break ... of biomedical engineering. He and his fellow researchers have ... thick layer between two surfaces. Pan,s nanoglue, which conducts ...
... In a brief paper in the journal Bioinformatics ... Web-based program called Spliceman for predicting whether genetic mutations ... potentially leading to disease. "Spliceman takes a set ... likely these single nucleotide variants alter splicing phenotypes," write ...
Cached Biology News:Discovery of a molecule that initiates maturation of mammalian eggs can lead to more IVF pregnancies 2Will a genetic mutation cause trouble? Ask Spliceman 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Biology Products: